Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Johan M. Spoor

At a glance: Johan M. Spoor is CEO at Perspective Therapeutics (CATX). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $38K. On file: 1 purchase line ($38K) and 0 sale lines ($0).

Disclosed holdings: about $79K of CATX stock: 106,383 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 20, 2026 close of $0.75. This counts only CATX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO at Perspective Therapeutics, Inc. (CATX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3K
Total bought / sold$38K / $0

Johan M. Spoor's InsiderPrint

5 trades from SEC Form 4 filings, 2024 to 2026, drawn as one fingerprint.

InsiderPrint of Johan M. Spoor: 5 trades, 2024 to 20262024: 3 buys, 0 sales2025: 1 buy, 0 sales2026: 1 buy, 0 sales

Reading this print: Almost only buys, trading about 2 times a year, typically $49K a trade; often buys after the stock has fallen 15% or more.

  • Bump outward: a purchase (5)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Ken JisserDirector · AUID · 100% matchTheir buys since 2023: 2 of 3 beat the S&P 500
  2. Thomas F. KirkDirector · MYO · 100% matchTheir buys since 2020: 1 of 6 beat the S&P 500
  3. Robert Clay GrantPresident · SLQT · 99% match
  4. Edward H. McKayCEO, President · SHEN · 99% match
  5. Mark Christopher MurraySvp - Acetyls · CE · 99% matchTheir buys since 2023: 3 of 7 beat the S&P 500

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2024

From the SEC's insider data sets: each open-market buy by Johan M. Spoor, matched to how the stock did over the next 90 days against the S&P 500.

1 of 2 buys beat the S&P 500 (50%), median +4.8% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CATXDec 6, 2024-22.7%
CATXJun 13, 2024+32.4%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC CATXPerspective Therapeutics, Inc.Stake +79%Past buys 1/2 beat S&P Buy 47,000106,383 held (+79%) $0.81 $38K -7.5%
  • Buy

    CEO Johan M. Spoor bought $38K of CATX at $0.81 — first open-market purchase in our records; raises the stake by 79%.

Follow Johan M. Spoor

Get one email when Johan M. Spoor files a new purchase or sale. Free.

At most one email a day about Johan M. Spoor, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.